Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
- Lisa A de Jong
- , Jessie Groeneveld
- , Jelena Stevanovic
- , Harrie Rila
- , Robert G Tieleman
- , Menno V Huisman
- , Maarten J Postma
- , Marinus van Hulst
Research output: Contribution to journal › Erratum
2
Citations
(Scopus)
111
Downloads
(Pure)